Showing results (151-160 of 198) with videos related to

Sort By:
Pageof 20
Cell Reports|June 29, 2017
A Critical Analysis of the Role of SNARE Protein SEC22B in Antigen Cross-PresentationS Julia Wu, Yashar S Niknafs, Stephanie H Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2016
Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host DiseaseHolly K Miller, Thomas M Braun, Terri Stillwell, et al.
Blood Advances|January 4, 2018
IAPs protect host target tissues from graft-versus-host disease in miceTomomi Toubai, Corinne Rossi, Katherine Oravecz-Wilson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2023
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) GuidelineHumera Khurshid, Nofisat Ismaila, Jessica Bian, et al.
Journal of Innate Immunity|November 21, 2016
Genome-Wide STAT3 Binding Analysis after Histone Deacetylase Inhibition Reveals Novel Target Genes in Dendritic CellsYaping Sun, Matthew Iyer, Richard McEachin, et al.
The Journal of Clinical Investigation|March 5, 2013
Blockade of individual Notch ligands and receptors controls graft-versus-host diseaseIvy T Tran, Ashley R Sandy, Alexis J Carulli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 4, 2012
TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomesSung W Choi, Patrick Stiff, Kenneth Cooke, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 18, 2024
From chest pain to coronary functional testing: Clinical and economic impact of coronary microvascular dysfunctionIlan Merdler, Ryan Wallace, Andrew P Hill, et al.
Annals of Hematology|March 19, 2015
Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remissionJohn M Magenau, Thomas Braun, Pavan Reddy, et al.
Blood|August 16, 2011
Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignanciesJohn Magenau, Hiromi Tobai, Attaphol Pawarode, et al.
Pageof 20